Cutler Group LP Medicinova Inc Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$2.19 - $2.81 $219 - $281	-100 Reduced 4.76%	2,000 $5,000
Q4 2021 Jan 18, 2022	BUY	$2.61 - $4.42 $261 - $442	100 Added 5.0%	2,100 $5,000
Q3 2021 Oct 26, 2021	SELL	$3.4 - $4.24 $1,924 - $2,399	-566 Reduced 22.06%	2,000 $7,000
Q2 2021 Jul 19, 2021	SELL	$3.76 - $5.14 $19,679 - $26,902	-5,234 Reduced 67.1%	2,566 $10,000
Q1 2021 Apr 26, 2021	BUY	$4.81 - $8.74 $36,556 - $66,424	7,600 Added 3800.0%	7,800 $39,000
Q2 2020 Jul 22, 2020	BUY	$3.06 - $7.06 $612 - $1,412	200 New	200 $1,000
Q2 2018 Aug 10, 2018	SELL	$7.96 - $13.23 $796 - $1,323	-100 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$6.6 - $13.91 $4,620 - $9,737	-700 Reduced 87.5%	100 $1,000
Q4 2017 Jan 17, 2018	BUY	$5.89 - $7.21 $4,712 - $5,768	800	800 $5,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.